相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility
B. Radha Krishnan et al.
JOURNAL OF ANTIBIOTICS (2017)
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms
Dominique Sanglard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
CD101: a novel long-acting echinocandin
Yanan Zhao et al.
CELLULAR MICROBIOLOGY (2016)
Antifungal drugs combinations: a patent review 2000-2015
Laura A. Svetaz et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates
Michael A. Pfaller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Francisco M. Marty et al.
LANCET INFECTIOUS DISEASES (2016)
How to bolster the antifungal pipeline
David W. Denning et al.
SCIENCE (2015)
Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using an In Vivo Murine Invasive Candidiasis Model
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
Cristina Jimenez-Ortigosa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Novel antifungal agents: a patent review (2011-present)
Maria Victoria Castelli et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Antifungal drug discovery: the process and outcomes
Richard Calderone et al.
FUTURE MICROBIOLOGY (2014)
Amphotericin forms an extramembranous and fungicidal sterol sponge
Thomas M. Anderson et al.
NATURE CHEMICAL BIOLOGY (2014)
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2013)
Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)
Michael A. Pfaller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Invasive Mycoses: Strategies for Effective Management
Dimitrios P. Kontoyiannis
AMERICAN JOURNAL OF MEDICINE (2012)
Amphotericin primarily kills yeast by simply binding ergosterol
Kaitlyn C. Gray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hidden Killers: Human Fungal Infections
Gordon D. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
New Lead Structures in Antifungal Drug Discovery
Chunquan Sheng et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002-2010)
Chiara Calugi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Management of invasive fungal infections: a role for polyenes
Pranatharthi Chandrasekar
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Echinocandins: Are They All The Same?
P. K. Mukherjee et al.
JOURNAL OF CHEMOTHERAPY (2011)
Antimicrobial peptides: General overview and clinical implications in human health and disease
Eduardo Guani-Guerra et al.
CLINICAL IMMUNOLOGY (2010)
Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
John W. Baddley et al.
CLINICAL INFECTIOUS DISEASES (2010)
An insight into the antifungal pipeline: selected new molecules and beyond
Luis Ostrosky-Zeichner et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Burkholdines 1097 and 1229, Potent Antifungal Peptides from Burkholderia ambifaria 2.2N
Kamilia A. Tawfik et al.
ORGANIC LETTERS (2010)
Therapy for fungal diseases: opportunities and priorities
David W. Denning et al.
TRENDS IN MICROBIOLOGY (2010)
Echinocandins: The Newest Class of Antifungals
Allana J. Sucher et al.
ANNALS OF PHARMACOTHERAPY (2009)
Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers
Ana Alastruey-Izquierdo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Amphotericin B and Its New Derivatives - Mode of Action
M. Baginski et al.
CURRENT DRUG METABOLISM (2009)
Resistance to antifungal agents: Mechanisms and clinical impact
Zeina A. Kanafani et al.
CLINICAL INFECTIOUS DISEASES (2008)
Changing epidemiology of systemic fungal infections
M. Richardson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Update on the epidemiology and diagnosis of invasive fungal infection
Manuel Cuenca-Estrella et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Mechanisms of resistance to antifungal agents: Yeasts and filamentous fungi
Ana Espinel-Ingroff
REVISTA IBEROAMERICANA DE MICOLOGIA (2008)
The cell wall:: a carbohydrate armour for the fungal cell
Jean-Paul Latge
MOLECULAR MICROBIOLOGY (2007)
The structure and synthesis of the fungal cell wall
Shaun M. Bowman et al.
BIOESSAYS (2006)
Invasive fungal pathogens: Current epidemiological trends
Michael A. Pfaller et al.
CLINICAL INFECTIOUS DISEASES (2006)
Biochemical characterization of recombinant dihydroorotate dehydrogenase from the opportunistic pathogenic yeast Candida albicans
Elke Zameitat et al.
FEBS JOURNAL (2006)
Antimicrobial peptides: therapeutic potential
LJ Zhang et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Interpretive breakpoints for fluconazole and Candida revisited:: a blueprint for the future of antifungal susceptibility testing
MA Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi
M Cuenca-Estrella et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Polymeric carriers for amphotericin B:: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice
MS Espuelas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Systemic mycoses in the immunocompromised host: an update in antifungal therapy
DP Kontoyiannis et al.
JOURNAL OF HOSPITAL INFECTION (2003)
Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei
C Onyewu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms
F Peláez et al.
SYSTEMATIC AND APPLIED MICROBIOLOGY (2000)
Discovery of novel antifungal (1,3)-β-D-glucan synthase inhibitors
J Onishi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
